# OXALIPLATIN
> **ANDA207474** · Abbreviated New Drug Application (Generic) · Sponsor: ACCORD HLTHCARE · Approved 2017-03-21
## Drug
- **FDA Application Number:** ANDA207474
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** OXALIPLATIN
- **Generic name:** OXALIPLATIN
- **Active ingredients:** OXALIPLATIN
- **Dosage form:** INJECTABLE
- **Route:** INTRAVENOUS
- **Marketing status:** Prescription
- **Sponsor:** ACCORD HLTHCARE
- **Manufacturer:** Accord Healthcare Inc.
- **First approval:** 2017-03-21
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=207474)
---
*AI Analytics · CC0 1.0*